108 related articles for article (PubMed ID: 23292061)
1. Retinal vein occlusion following intravenous immunoglobulin treatment.
Nawasiwatte BM; Somaratne SC; Fernando A; Gunaratne PS
Ceylon Med J; 2012 Dec; 57(4):170-1. PubMed ID: 23292061
[No Abstract] [Full Text] [Related]
2. Acute generalized exanthematous pustulosis following intravenous immunoglobulin.
Moon SH; Shin MK
Indian J Dermatol Venereol Leprol; 2012; 78(6):774. PubMed ID: 23075659
[No Abstract] [Full Text] [Related]
3. Anaphylaxis with intravenous immunoglobulin: a time for introspection.
Jain RS; Agrawal R; Kumar S; Gupta PK
Am J Emerg Med; 2015 Sep; 33(9):1332.e1-2. PubMed ID: 25819200
[No Abstract] [Full Text] [Related]
4. Stroke after intravenous gamma globulin.
Saeed F; Siddiqi NF; Dorairaj K; Laurence TN
Neurol India; 2010; 58(6):960-2. PubMed ID: 21150074
[No Abstract] [Full Text] [Related]
5. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
Koichihara R; Hamano S; Yamashita S; Tanaka M
Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
[TBL] [Abstract][Full Text] [Related]
8. [Case of herpes zoster associated Guillain-Barré syndrome with a relapse of eruptions after intravenous immunoglobulin therapy].
Nagane Y; Utsugisawa K; Obara D
Rinsho Shinkeigaku; 2006 Sep; 46(9):664-7. PubMed ID: 17260813
[TBL] [Abstract][Full Text] [Related]
9. [Images in Medicine. Occlusion of the central vein of the retina after treatment with intravenous human immunoglobulin].
Palácio GL; Gabbai AA; Muccioli C; Belfort R
Rev Assoc Med Bras (1992); 2004; 50(3):246. PubMed ID: 15499469
[No Abstract] [Full Text] [Related]
10. Unraveling Guillain-Barré syndrome.
Castro MC
Nurs Manage; 2010 Aug; 41(8):36-9; quiz 39-40. PubMed ID: 20671533
[No Abstract] [Full Text] [Related]
11. Emerging drugs for Guillain-Barré syndrome.
Walgaard C; Jacobs BC; van Doorn PA
Expert Opin Emerg Drugs; 2011 Mar; 16(1):105-20. PubMed ID: 21352072
[TBL] [Abstract][Full Text] [Related]
12. Central retinal vein occlusion complicating treatment with intravenous immunoglobulin.
Harkness KA; Goulding P
Eye (Lond); 2000 Aug; 14 ( Pt 4)():662-3. PubMed ID: 11040920
[No Abstract] [Full Text] [Related]
13. Guillain-Barré syndrome as first presentation of systemic lupus erythematosus: a rare manifestation complicated by IVIg-induced splenic infarct.
Fazio RM; Chen I; Somal N
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26607185
[TBL] [Abstract][Full Text] [Related]
14. Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome.
Odaka M; Tatsumoto M; Hoshiyama E; Hirata K; Yuki N
Eur Neurol; 2005; 53(4):194-6. PubMed ID: 15970631
[TBL] [Abstract][Full Text] [Related]
15. Individual patients who experienced both Guillain-Barré syndrome and CIDP.
Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
[No Abstract] [Full Text] [Related]
16. [Intravenous immunoglobulin therapy in neuroimmunological disorders].
Komoly S
Ideggyogy Sz; 2014 Jul; 67(7-8):281-2. PubMed ID: 25509371
[No Abstract] [Full Text] [Related]
17. Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre Syndrome.
Uygur Kucukseymen E; Yuksel B; Genc F; Ozaydin Goksu E; Yildiz S; Bicer Gomceli Y
Clin Neuropharmacol; 2017; 40(5):224-225. PubMed ID: 28816832
[TBL] [Abstract][Full Text] [Related]
18. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
[TBL] [Abstract][Full Text] [Related]
19. Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
Rhee DY; Park GH; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
J Eur Acad Dermatol Venereol; 2009 May; 23(5):602-4. PubMed ID: 18761548
[No Abstract] [Full Text] [Related]
20. Intravenous immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
DiMario FJ
Pediatrics; 2005 Jul; 116(1):226-8. PubMed ID: 15995056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
